Join
Live feed
·
INSIDERFilingvia Quantisnow
Caladrius Biosciences Inc. logo

SEC Form 4: Ruoslahti Erkki was granted 20,000 shares

ByQuantisnow·Wall Street's wire, on your screen.
CLBS· Caladrius Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLBS (Caladrius Biosciences Inc.) and more on Quantisnow.

SEC Form 4: Ruoslahti Erkki was granted 20,000 shares | Quantisnow